Introduction {#s0005}
============

Intracranial aneurysm (IA) accounts for 85% of Subarachnoid Hemorrhage (SAH), which contributes for 5--15% of strokes, but occurs at a fairly young age ([@bb0015]). Reports have shown a worldwide incidence of aSAH (aneurysmal Subarachnoid Hemorrhage) in 10.5 cases per 100,000 person-years ([@bb0035]). In general population 2--3% individual harbor intracranial aneurysm ([@bb0090]). Prevalence of intracranial aneurysm in India based on autopsies ranges from 0.2% to 10.3% from various parts of India, with a mean prevalence of 5.3% ([@bb0005], [@bb0055], [@bb0080]). Familial clustering of intracranial aneurysm is reported with a four-fold risk of aneurismal rupture in a first degree relative and identical aneurysm location in twins supports the genetic cause ([@bb0065], [@bb0140]). Hypertension and smoking may be causal risk factors which might also modify the effect of genetic factors that could increase susceptibility to aSAH in the Indian population ([@bb0060]).

Various theories have been proposed for the development of aneurysm and most of these theories reflect on the imbalances in the extracellular matrix (ECM) remodeling. ECM remodeling plays an important role in maintaining the structure and integrity of the intracranial arteries. Reduced extracellular matrix is a prominent feature of cerebral aneurysms. In an earlier study we reported that lysyl oxidase (LOX) is an enzyme which is involved in covalent cross linking of these fibrous proteins by the formation of aldehydes between lysine residues that insolubilize these extracellular proteins namely collagen and elastin ([@bb0050]), thus giving strength to intracranial arteries was not found to be associated with IA in our study population ([@bb0105]). Proteoglycan Versican (*VCAN*) is a putative candidate gene for IAs as it plays an important role in extracellular matrix assembly and is localized near a previously implicated locus for IAs on chromosome 5q22--31 ([@bb0075]).

*VCAN* gene localized on 5q12--q14 has 15 exons ([@bb0040]) codes for large 372.82 kDa chondroitin sulfate proteoglycan found abundantly in the extracellular matrix and plays many pivotal roles in maintaining the functions of extracellular matrix. Versican plays an important role in cell adhesion by connecting the cell to the extracellular matrix with interacting partners hyaluronan, type I collagen, tenascin-R, fibulin-1 and -2, fibrillin-1, fibronectin, P- and L-selectins, and chemokines ([@bb0155]) and also in proliferation, migration and angiogenesis ([@bb0130]). Two largest exon 7 and exon 8 encodes for glycosaminoglycan (GAG) attachment sites, GAG alpha and GAG beta respectively. Alternate splicing at this region results in four transcripts; V0 possesses both exon 7 and exon 8, V1 possesses exon 8 but lacks exon 7, V2 possesses exon 7 but lacks exon 8; and V3 possesses neither exons ([@bb0130]). Polymorphism in these regions of the gene can have differential effects which can also have its effects in ethnic specific manner as polymorphisms are known to be ethnicity specific. To date no study has been carried out in these functionally coding regions of the gene and its role in intracranial aneurysms. Linkage studies have indicated 5q12--q14 which harbors the *VCAN* gene and two SNPs rs251124 and rs173686 which are upstream to exon 7 have been reported to be associated with aneurysm in a Dutch population. However, replication studies in different ethnicities on the linkage regions provided conflicting results in regard to intracranial aneurysm ([@bb0095], [@bb0100], [@bb0120], [@bb0160]). In the present study we intend to explore the role of *VCAN* gene variants rs251124 and rs173686 along with four other nonsynonymous SNP variants rs2287926, rs188703, rs309559 and rs160277 in GAG-α and GAG-β coding exon 7 and exon 8 with intracranial aneurysm in the south Indian population.

Materials and methods {#s0010}
=====================

Study population {#s0025}
----------------

The study populations consist of radiologically confirmed 220 aneurismal cases and 250 ethnically and age matched controls from the Dravidian Malayalam speaking population of South India. This was specifically done to avoid stratification issues ([@bb0125]). Inclusion criteria include saccular intracranial aneurysm detected using CT scan, and location and type of aneurysm were confirmed by digital subtraction angiography (DSA). Exclusion criteria include patient with non-saccular aneurysm, arteriovenous malformation (AVM) and other hereditary connective tissue disorders like autosomal dominant polycystic kidney disease, Marfan syndrome, and Ehler Danlos syndrome. Cases were recruited from two main tertiary care neurosurgical centers in Kerala. All patients were rated based on WFNS scale. The control population consists of age, sex and ethnicity matched individuals who were symptomatically normal and did not possess any symptoms or family history of intracranial aneurysm. The study was as per the ICMR guidelines and approved by Institute Ethical Committee (IEC).

SNP selection and genotyping {#s0030}
----------------------------

SNPs were selected based on the functional relevance and minor allele frequency using genotype data obtained from Caucasian individuals in the HapMap project (HapMap Data Rel 24/Phase II Nov08, on NCBI B36 assembly, dbSNP b126). Four nonsynonymous SNPs were selected which includes SNPs in functionally significant motif GAG-α and GAG-β present in VCAN propeptide, rs2287926 (G428D), rs160277 (D1950Y), rs188703 (R839H) and rs309559 (K529R), along with two other SNPs, rs251124 and rs173686 which were selected based on their presumed role in RNA splicing of this functionally significant motif and previous association in Dutch population ([@bb0095]). Genotyping for rs2287926 (G428D), rs160277 (D1950Y), rs188703 (R839H) and rs309559 (K529R) was performed by fluorescence-based competitive allele-specific PCR (KASPar) chemistry (Kbiosciences, UK) while rs251124 and rs173686 were based on sequencing (ABI PRISM Big Dye Terminator v3.1 cycle sequencing kit) according to the manufacturer\'s instructions, and was analyzed using the ABI PRISM 3730 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) (Supplementary Table 1). The KASPar reaction comprised of 8 μl with 5 ng of DNA, 0.11 μl of assay mix and 4 μl of reaction mix and the PCR was performed in ABI 7500 real-time PCR System (Applied Biosystems, Foster City, CA, USA). The cycling conditions were as follows: 94 °C for 15 min (Hot-start enzyme activation, 94 °C for 20 s, a touchdown step for 10 cycles over 65--57 °C for 60 s (dropping 0.8 °C per cycle), and a final 26 step cycle with 94 °C for 20 s and 57 °C for 60 s). Further, the genotype calling based on the respective allele specific fluorescence was done by allelic discrimination utility of the SDS 7500 v2.0.5 software at an ambient temperature of 25 °C and genotype clusters were plotted.

Statistical analysis {#s0035}
--------------------

Genotype and allele frequencies were computed and were checked for deviation from Hardy--Weinberg equilibrium (ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). All statistical analyses were performed using the Graph Pad Prism 5.01, San Diego, CA, USA. We considered *P*-value of \< 0.05 as significant. Chi-square test and allelic odds ratios (OR) and 95% confidence intervals (CI) were calculated by Fisher\'s exact test (two-tailed). To estimate LD between pairs of loci in the patient and control populations, standardized disequilibrium coefficient (D′) and squared correlation coefficient (r^2^) were calculated using Haploview 4.1 ([www.broad.mit.edu/mpg/haploview/](http://www.broad.mit.edu/mpg/haploview/){#ir0020}) ([@bb0010]). LD blocks were defined in accordance with Gabriel\'s criteria ([@bb0025]). Further stratification of the patients based on sex and hypertension status was done to understand the role of *VCAN* variant within the sexes and between the hypertensive and non-hypertensive groups. However due to the exploratory nature of this study, no adjustment for multiple testing was made, as not to penalize ourselves by missing possibly important findings. rs251124 has been studied in populations including Dutch, Japanese and Chinese. Further, a meta-analysis of the studies with the random-effects and fixed-effects models was performed using Review Manager 5.2 (reviewmanager.software.informer.com/5.2/). The inconsistency index I^2^ was used to assess between-study heterogeneity. Functional prediction of the deleterious effect if any, of the associated SNP with respect to the functional categories such as protein coding, splicing regulation, transcriptional regulation, and post-translation was assessed in-silico using F-SNP program (compbio.cs.queensu.ca/F-SNP/), FastSNP (fastsnp.ibms.sinica. edu.tw), SNP Function Prediction (FuncPred) (snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm), SNP Nexus ([www.snp-nexus.org/](http://www.snp-nexus.org/){#ir0025}), and HaploReg ([www.broadinstitute.org/mammals/haploreg](http://www.broadinstitute.org/mammals/haploreg){#ir0030}).

F-SNP extracts information from large number of resources such as PolyPhen, SIFT, SNPeffect, SNPs3D, LS-SNP, Ensembl, ESEfinder, RescueESE, ESRSearch, PESX, TFSearch, Consite, GoldenPath, KinasePhos, OGPET, and Sulfinator to generate a Functional Significance (FS) score.

Results {#s0015}
=======

The demographic and clinical characteristics of the patients and controls are summarized in [Table 1](#t0005){ref-type="table"}. All the six SNPs screened were found to be polymorphic and were in Hardy--Weinberg equilibrium (*P* ≥ 0.05) in healthy controls. We observed a novel and significant association of the non-synonymous variant rs2287926 (Gly428Asp) present in the GAG-α domain of VCAN. This association was observed at allelic (*P* = 0.0015, *P*~corrected~ = 0.009, OR = 1.635, CI = 1.207 to 2.215) and genotypic levels (*P* = 0.0031, *P*~corrected~ = 0.0186), where A allele poses a higher risk at both allelic and genotypic combinations ([Table 2](#t0010){ref-type="table"}). None of the other non-synonymous variants in *VCAN* were found to differ in genotype and allele frequency distribution in our study samples ([Table 2](#t0010){ref-type="table"}).

While replicating the previously reported associated variants, rs251124 and rs173686 which were presumed to have a role in RNA splicing of GAG domains, we could observe a significant association with rs251124 at allelic (*P* = 0.0042, *P*~corrected~ = 0.0252, OR = 1.511, CI = 1.141 to 2.002) and genotypic (*P* = 0.0002, *P*~corrected~ = 0.0012) levels ([Table 2](#t0010){ref-type="table"}). The T allele was found to be significantly higher in aneurismal cases when compared to similar ethnic controls. At genotype level, CT genotype was found to be associated with intracranial aneurysm. Our study could not replicate the association with rs173686 at genotypic and allelic levels with intracranial aneurysm in the south Indian population.

Interestingly, we also observed that rs2287926 (Gly428Asp) A allele contributes to significantly higher risk for males at both allelic (*P* = 0.02, OR = 1.87, CI = 1.19--2.93) and genotypic levels (*P* = 0.008) when stratified based on sex ([Table 3](#t0015){ref-type="table"}). While further stratifying the patient group based on hypertensive and non-hypertensive status we observed that the genetic risk contributed by rs251124 and rs2287926 (Gly428Asp) for intracranial aneurysm was independent of hypertension status ([Table 4](#t0020){ref-type="table"}).

In silico analysis for the functional prediction of the variants in the present study indicated that rs2287926 had the highest functional significance with a functional score (FS) of 0.640. Polyphen predicted that this variant has a potential damaging effect on phenotype. Functional prediction of rs2287926 also suggested that it might have a potentially altered regulatory role in transcription and splicing. The SNP rs251124 has also been predicted to have altered transcriptional regulation ([Table 5](#t0025){ref-type="table"}) but was found to be of lesser functional significance when compared to rs2287926.

Subsequently we also carried out a meta-analysis of our observation with the previously reported studies to compare the prevalence of the associated variants of *VCAN* rs251124 and rs173686 among IA and controls, using both fixed and random-effects models. A significant association was observed in both random-effects and fixed-effects models for rs251124 (T v/s C; *P* = 0.0001, OR = 1.26, CI = 1.11--1.46), and heterogeneity among the studies was observed to be 24% from the I^2^ values ([Fig. 1](#f0005){ref-type="fig"}). The south Indian population displayed a similar trend of association for aneurismal risk to the European population. However, the meta-analysis of rs173686 could not predict any significant association with IA susceptibility by either models (A v/s G; *P* = 0.06, OR = 1.15, CI = 1.00--1.33) and the heterogeneity was high (I^2^ = 68%) among the studies.

Discussion {#s0020}
==========

The characteristic feature of IA is the ballooning of intracranial arteries which is indicative of weakening of arterial walls and thus one can speculate the role of defective ECM maintenance in IA pathogenesis ([@bb0135]). Versican plays a prominent role in the maintenance of extracellular matrix structure. It has also been implicated in cell proliferation ([@bb0085], [@bb0130]), cell adhesion ([@bb0150]), cell migration and invasion ([@bb0030]). *VCAN* gene is known to produce four isoforms V0, V1, V2 and V3 by alternate splicing of exon 7 and exon 8 ([@bb0020]). V1 isoform contains GAG-β and lacks GAG-α domain while V2 isoform contains GAG-α and lacks GAG-β domain ([@bb0070]). The GAG-α and GAG-β are the key glycosaminoglycan binding G2 domain of Versican proteoglycan which are encoded by exons 7 and 8. In the present study we analyzed the genetic variants in these domains represented by rs2287926 in exon 7 (coding GAG-α) and rs160277, rs188703 and rs309559 in exon 8 (coding GAG-β). Our study revealed a novel association for nonsynonymous variant rs2287926 (G428D) in exon 7 coding for GAG-α domain where A allele was found to be a risk allele for intracranial aneurysm in the south Indian population. We also carried out a replication study of the two previously reported associated variants rs251124 and rs173686 for intracranial aneurysm in the south Indian population. rs251124 and rs173686 are present in the intronic regions upstream to exon 7. Interestingly one of the SNP rs251124 was found to be strongly associated with aneurysm in our study population. This observation is interesting as rs251124 was found to be associated across all ethnicities as evidenced from our meta-analysis. However, rs173686 was not found to be associated in the study population as well as in the meta-analysis. This could be due to the influence of Asian ethnicities as in Chinese population rs173686 was also not found to be associated with aneurysm ([@bb0100], [@bb0120]). The odds ratio for rs251124 in the south Indian population was similar to the European population. Interestingly the allele and genotype frequencies for rs251124 when compared to the 1000 genome population were also similar to the European population while rs2287926 was similar to Asian ethnic populations (Supplementary Figs. 1 and 2). From the allele and genotype frequencies of the 1000 genome population it is evident that the intronic SNPs in the South Indian population were similar to the European population while the exonic associated SNPs were similar to the Asian ethnicity. This suggests for a different level of selection pressures in intronic and the functional exonic regions of the *VCAN* gene.

To date no study has implicated the role of functional variants in *VCAN* to be associated with intracranial aneurysm. However, functional variants in this gene have been implicated in cancer. In an earlier study in a Korean population the genetic variants in the GAG-β domain of *VCAN* A1826H and D2937Y have been reported to influence susceptibility to intestinal-type gastric cancer ([@bb0045]). This observation is interesting as we observe that it is not the GAG-β domain but instead the genetic variant in the GAG-α domain rs2287926 (G428D) in exon 7 results in the development of aneurysm. This study clearly demonstrates that different domains in the *VCAN* gene associate differently with intracranial aneurysm and gastric cancer phenotype. This contrasting observation in the present study could be explained with following reasons at functional level. It has been reported that V1 and V2 isoforms behave differently with opposite biological activity ([@bb0115]). V1 isoform harboring GAG-β domain enhances cell proliferation, modulates cell cycle progression and protects cells from apoptosis, which clearly supports the variants\' role in causing a cancerous phenotype while V2 isoform harboring the GAG-α domain inhibits cell proliferation and expression of EGFR and cyclin A and does not protect cell from apoptosis ([@bb0115]). Further *VCAN* V1 isoform induces neuronal differentiation and promotes neurite outgrowth ([@bb0145]) while V2 inhibit axonal growth ([@bb0110]). A similar phenotype shown by the V2 isoform may be contributing to the inhibition of the growth of smooth muscle and other vascular entities causing intracranial aneurysm. Interestingly the associated variants rs251124 and rs2287926 (Gly428Asp) for intracranial aneurysm was found to be independent of confounding factors such as hypertension status.

We conclude that this study confirms the association of rs251124 with intracranial aneurysm as a global marker however, its exact functional role is still not very clear. In addition we report a novel function variant rs2287926 (G428D) in the GAG-α domain of *VCAN* gene which might have a potentially altered regulatory role in transcription and splicing. Interestingly, this variant poses a higher risk for males independent of its confounding factors such as hypertension. Thus *VCAN* is an important candidate gene involved in the pathogenesis of intracranial aneurysm.

Appendix A. Supplementary data {#s0045}
==============================

Supplementary Fig. 1: Genotype frequency comparison of rs2287926, rs173686 and rs251124 in different ethnic population obtained from 1000 genome population data.Supplementary Fig. 2: Allelic frequency comparison of rs2287926, rs173686 and rs251124 in different ethnic population obtained from 1000 genome population data.
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###### 

Clinical characteristics of patients.

  Characteristics                  Cases           Controls
  -------------------------------- --------------- -------------
  Mean age ± SD, years             51.17 ± 11.37   51.0 ± 14.1
  Men, %                           55.7            48.7
  Women, %                         44.2            51.3
  History of hypertension,%        35              16
  History of diabetes, %           5.4             14.7
  Family history of aSAH, %        3.7             0
  Cigarette smoking, %             42.92           18
  Alcohol use, %                   21.8            12
                                                   
  Intracranial aneurysm location   Percentage      
                                                   
  Anterior communicating artery    39.21           --
  Anterior cerebral artery         8.37            --
  Middle cerebral arteries         22.91           --
  Internal carotid artery          17.18           --
  Posterior communicating artery   8.81            --
  Basilar artery                   2.64            --
  Posterior cerebral artery        0.44            --
  Vertebral arteries               0.44            --

###### 

Comparison of the genotype and allele frequencies of *VCAN* gene variants between patients and control.

                      CC      CT      TT      *P*-value   C     T     OR (95% CI)                *P*-value
  ----------- ------- ------- ------- ------- ----------- ----- ----- -------------------------- -----------
  rs251124    Cases   81      113     18      0.0002      275   149   0.6616(0.4995 to 0.8764)   0.0042
  0.382       0.533   0.085   0.649   0.351                                                      
  Controls    142     87      23      371     133                                                
  0.563       0.345   0.091   0.736   0.264                                                      
                                                                                                 
                      GG      AG      AA                  G     A                                
                                                                                                 
  rs173686    Cases   56      107     46      0.6038      219   199   1.058(0.8156 to 1.371)     0.6913
  0.268       0.512   0.220   0.524   0.476                                                      
  Controls    69      118     64      256     246                                                
  0.275       0.470   0.255   0.510   0.490                                                      
                                                                                                 
                      AA      AG      GG                  A     G                                
                                                                                                 
  rs2287926   Cases   13      94      98      0.0031      120   290   1.635(1.207 to 2.215)      0.0015
  0.063       0.459   0.478   0.293   0.707                                                      
  Controls    10      83      162     103     407                                                
  0.039       0.325   0.635   0.202   0.798                                                      
                                                                                                 
                      CC      CT      TT                  C     T                                
                                                                                                 
  rs309559    Cases   30      95      74      0.3033      155   243   1.212(0.9220 to 1.594)     0.1841
  0.151       0.477   0.372   0.389   0.611                                                      
  Controls    26      119     103     171     325                                                
  0.105       0.480   0.415   0.345   0.655                                                      
                                                                                                 
                      CC      CT      TT                  C     T                                
                                                                                                 
  rs 188703   Cases   117     72      14      0.9368      306   100   1.009(0.7453 to 1.367)     1
  0.576       0.355   0.069   0.754   0.246                                                      
  Controls    143     93      16      379     125                                                
  0.567       0.369   0.063   0.752   0.248                                                      
                                                                                                 
                      CC      AC      AA                  C     A                                
                                                                                                 
  rs160277    Cases   118     75      17      0.676       311   109   0.9761(0.7264 to 1.312)    0.8804
  0.562       0.357   0.081   0.740   0.260                                                      
  Controls    141     98      16      380     130                                                
  0.553       0.384   0.063   0.745   0.255                                                      

###### 

Comparison of the genotype and allele frequencies of rs251124 and rs2287926 *VCAN* gene variants within males and females in cases and control.

              Male     CC      CT      TT      *P*-value   C       T       OR (95% CI)                *P*-value
  ----------- -------- ------- ------- ------- ----------- ------- ------- -------------------------- -----------
  rs251124    Case     0.400   0.530   0.070   0.0017      0.665   0.335   0.5326(0.3283 to 0.8639)   0.0124
  Control     0.654    0.269   0.077   0.788   0.212                                                  
                                                                                                      
              Female   CC      CT      TT                  C       T                                  
                                                                                                      
  rs251124    Case     0.549   0.378   0.073   0.0773      0.738   0.262   1.635(1.022 to 2.615)      0.0443
  Control     0.373    0.518   0.108   0.633   0.367                                                  
                                                                                                      
              Male     AA      AG      GG                  A       G                                  
                                                                                                      
  rs2287926   Case     0.070   0.440   0.490   0.0391      0.290   0.710   1.805(1.100 to 2.962)      0.0204
  Control     0.012    0.345   0.643   0.185   0.815                                                  
                                                                                                      
              Female   AA      AG      GG                  A       G                                  
                                                                                                      
  rs2287926   Case     0.073   0.427   0.500   0.3209      0.287   0.713   1.465(0.8810 to 2.436)     0.1583
  Control     0.038    0.354   0.608   0.215   0.785                                                  

###### 

Comparison of the genotype and allele frequencies of rs251124 and rs2287926 *VCAN* gene variants within patient with hypertension and non-Hypertensive status.

  SNP         Hypertension status   CC      CT      TT      *P*-value   C       T       OR (95% CI)               *P*-value
  ----------- --------------------- ------- ------- ------- ----------- ------- ------- ------------------------- -----------
  rs251124    Hyp +                 0.391   0.563   0.047   0.2119      0.672   0.328   1.103(0.6950 to 1.749)    0.7258
  Hyp-        0.418                 0.464   0.118           0.650       0.350                                     
                                                                                                                  
                                    AA      AG      GG                  A       G                                 
                                                                                                                  
  rs2287926   Hyp +                 0.091   0.364   0.545   0.339       0.273   0.727   0.8967(0.5576 to 1.442)   0.7185
  Hyp-        0.060                 0.470   0.470           0.295       0.705                                     

###### 

Prediction of effect of studied SNPs in this study using F-SNP database.

  SNP                          Functional category          Prediction tool   Prediction result   Functional information
  ---------------------------- ---------------------------- ----------------- ------------------- ------------------------
  rs160277 (D1950Y)            protein_coding               PolyPhen          Possibly damaging   FS score = 0.560
  SIFT                         Damaging                                                           
  SNPeffect                    Deleterious                                                        
  LS-SNP                       Benign                                                             
  SNPs3D                       No entry                                                           
  Ensembl-NS                   Nonsynonymous                                                      
  splicing_regulation          ESEfinder                    Changed                               
  ESRSearch                    changed                                                            
  PESX                         Changed                                                            
  RESCUE_ESE                   Not changed                                                        
  transcriptional_regulation   GoldenPath                   Exist                                 
  post_translation             OGPET                        Not exist                             
  Sulfinator                   Not exist                                                          
  rs188703 (R839H)             protein_coding               PolyPhen          Benign              FS score = 0.5
  SIFT                         Tolerated                                                          
  SNPeffect                    Benign                                                             
  LS-SNP                       Benign                                                             
  SNPs3D                       No entry                                                           
  Ensembl-NS                   Nonsynonymous                                                      
  splicing_regulation          ESEfinder                    Changed                               
  ESRSearch                    Changed                                                            
  PESX                         Changed                                                            
  RESCUE_ESE                   Not changed                                                        
  transcriptional_regulation   GoldenPath                   Exist                                 
  post_translation             OGPET                        Exist                                 
  Sulfinator                   Not processed                                                      
  rs309559 (K529R)             protein_coding               PolyPhen          Benign              FS score = 0.347
  SIFT                         Tolerated                                                          
  SNPeffect                    Deleterious                                                        
  LS-SNP                       Benign                                                             
  SNPs3D                       No entry                                                           
  Ensembl-NS                   Nonsynonymous                                                      
  splicing_regulation          ESEfinder                    Changed                               
  ESRSearch                    Changed                                                            
  PESX                         Not changed                                                        
  RESCUE_ESE                   Not changed                                                        
  transcriptional_regulation   GoldenPath                   Exist                                 
  post_translation             OGPET                        Not exist                             
  Sulfinator                   Not exist                                                          
  rs2287926 (G428D)            protein_coding               PolyPhen          Possibly damaging   FS score = 0.640
  SIFT                         Tolerated                                                          
  SNPeffect                    Benign                                                             
  LS-SNP                       Benign                                                             
  SNPs3D                       No entry                                                           
  Ensembl-NS                   Nonsynonymous                                                      
  splicing_regulation          ESEfinder                    Changed                               
  ESRSearch                    Changed                                                            
  PESX                         Changed                                                            
  RESCUE_ESE                   Not changed                                                        
  transcriptional_regulation   GoldenPath                   Exist                                 
  post_translation             OGPET                        Not exist                             
  Sulfinator                   Not exist                                                          
  rs251124                     transcriptional_regulation   GoldenPath        Exist               FS score = 0.101
  rs173686                     transcriptional_regulation   GoldenPath        Exist               FS score = 0.101
